Tempus AI (TEM) Projected to Post Quarterly Earnings on Friday

Key Points

• Tempus AI is set to announce its Q2 2025 quarterly earnings on August 8th, with analysts predicting earnings of ($0.23) per share and revenue of $296.84 million.
• In its previous earnings report, the company exceeded expectations by posting ($0.24) earnings per share and $255.74 million in revenue, reflecting a 75.4% year-over-year increase.
• The stock has seen fluctuations with a current price of $56.59, having a 52-week range between $31.36 and $91.45, and analysts have given a moderate buy rating with a target price averaging $65.09.

Tempus AI (NASDAQ:TEM - Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Friday, August 8th. Analysts expect the company to announce earnings of ($0.23) per share and revenue of $296.84 million for the quarter. Tempus AI has set its FY 2025 guidance at EPS.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The firm's revenue was up 75.4% compared to the same quarter last year. On average, analysts expect Tempus AI to post $-6 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Tempus AI Price Performance

Shares of Tempus AI stock traded down $1.70 during midday trading on Friday, hitting $54.89. 6,557,804 shares of the company traded hands, compared to its average volume of 8,155,137. The stock has a market cap of $9.50 billion, a price-to-earnings ratio of -7.04 and a beta of 4.99. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. The firm's fifty day moving average price is $62.47 and its 200-day moving average price is $57.29. Tempus AI has a 12 month low of $31.36 and a 12 month high of $91.45.

Insider Activity

In other news, EVP Erik Phelps sold 51,317 shares of the company's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the sale, the executive vice president directly owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. This represents a 34.42% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the company's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $62.87, for a total transaction of $10,452,137.50. Following the completion of the sale, the chief executive officer directly owned 9,274,033 shares in the company, valued at approximately $583,058,454.71. This represents a 1.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 778,772 shares of company stock worth $52,052,375. Company insiders own 27.60% of the company's stock.

Institutional Investors Weigh In On Tempus AI

A hedge fund recently raised its stake in Tempus AI stock. Royal Bank of Canada lifted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 201.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 25,988 shares of the company's stock after acquiring an additional 17,359 shares during the period. Royal Bank of Canada's holdings in Tempus AI were worth $1,253,000 at the end of the most recent reporting period. 24.22% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on TEM shares. Piper Sandler lifted their price target on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Guggenheim lifted their price target on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a report on Monday, June 30th. Morgan Stanley lifted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price target on the stock. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $65.09.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.